$3.3 Million Bet On This Technology Stock? 3 Stocks Insiders Are Buying
$3.3 Million Bet On This Technology Stock? 3 Stocks Insiders Are Buying
Although US stocks closed higher on Monday, there were a few notable insider trades.
儘管美國股市週一收盤走高，但仍有一些值得注意的內幕交易。
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
當內部人士購買股票時，這表明他們對公司的前景充滿信心，或者他們認為這隻股票很划算。無論哪種方式，這都標誌着做多該股的機會。內幕收購不應被視為做出投資或交易決定的唯一指標。充其量，它可以讓買入決定更有説服力。
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
以下是最近幾筆值得注意的內幕交易。欲瞭解更多信息，請查看Benzinga的內幕交易站臺。
Ivanhoe Electric
艾芬豪電氣
- The Trade: Ivanhoe Electric Inc. (NYSE:IE) CEO Robert M Friedland acquired a total of 416,666 shares an average price of $8.00. To acquire these shares, it cost around $3.33 million.
- What's Happening: JP Morgan, last month, initiated coverage on Ivanhoe Electric with a Neutral rating and announced a price target of $12.
- What Ivanhoe Electric Does: Ivanhoe Electric Inc is a mineral project exploration and development company with a focus on identifying and developing mineral projects, and ultimately mines, associated with the metals necessary for electrification, in particular, copper, gold, silver, nickel, cobalt, vanadium, and the platinum group metals.
- 行業： 艾芬豪電氣公司(紐約證券交易所股票代碼：IE)首席執行官羅伯特·M·弗裏德蘭共購入416,666股平均價格為8美元。收購這些股份的成本約為333萬美元。
- 正在發生的事情：上個月，摩根大通(JP Morgan)對艾芬豪電氣(Ivanhoe Electric)發起了中性評級，並宣佈目標價為12美元。
- 艾芬豪電氣的業務：艾芬豪電氣公司是一家礦產項目勘探和開發公司，專注於識別和開發礦產項目，並最終開發與電氣化所需的金屬相關的礦產項目，特別是銅、金、銀、鎳、鈷、釩和鉑族金屬。
Third Harmonic Bio
三次諧音生物
- The Trade: Third Harmonic Bio, Inc. (NASDAQ:THRD) 10% owner Atlas Venture Associates Opportunity I, LLC acquired a total of 7,366,470 shares at an average price of $17.00. To acquire these shares, it cost around $5.1 million.
- What's Happening: The company recently priced its IPO at $17 per share.
- What Third Harmonic Bio Does: Third Harmonic Bio Inc is a clinical-stage company developing a novel oral approach to the treatment of severe allergy and inflammation.
- 行業： 第三諧音生物公司。(納斯達克：TRRD)10%股權阿特拉斯風險投資公司機會I，有限責任公司共購入7,366,470股平均價格為17.00美元。收購這些股份的成本約為510萬美元。
- 正在發生的事情：該公司最近將首次公開募股(IPO)定價為每股17美元。
- Third Harmonic Bio的用途：Third Harmonic Bio Inc.是一家臨牀階段的公司，正在開發一種治療嚴重過敏和炎症的新的口服方法。
Don't forget to check out our premarket coverage here .
別忘了在這裏查看我們的售前報道。
Also check this: Dow, Nasdaq Futures Lower Ahead Of Fed Meeting
另請查看：道瓊斯指數，納斯達克期貨在美聯儲會議前下跌
Spok Holdings
SPOK控股
- The Trade: Spok Holdings, Inc. (NASDAQ:SPOK) Director Todd J Stein bought a total of 139,704 shares at an average price of $7.29. To acquire these shares, it cost around $1.02 million.
- What's Happening: The company's stock tumbled around 11% over the past six months.
- What Spok Holdings Does: Spok Holdings Inc is a provider of healthcare communications. It reports three market segments namely Healthcare, Government, and Large enterprise .
- 行業： SPOK控股公司(納斯達克：SPOK)董事託德·J·斯坦共買入139,704股平均價格為7.29美元。收購這些股份的成本約為102萬美元。
- 正在發生的事情：該公司的股票在過去六個月裏暴跌了約11%。
- Spok Holdings的業務：SPOK控股公司是一家醫療保健通信提供商。它報告了三個細分市場，即醫療保健、政府和大型企業。
譯文內容由第三人軟體翻譯。